San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts ...

Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...

The GLP-1 drugs, including Mounjaro and Wegovy, work by mimicking the action of hormones that make you feel full, while ...

A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...

Maria AbiHanna, a Dubai-based dietician said six certain food groups 'can do the same thing naturally, without the nausea'.

Novo Nordisk A/S (NYSE:NVO) is one of the 12 stocks that will make you rich in 10 years. On June 23, the company discontinued ...

More than 20 million people globally are injecting themselves with GLP-1s... Weight-loss pills will only see that explode ...

Group Captain Shubhanshu Shukla has become the first Indian to reach the International Space Station (ISS) on the Axiom-4 ...

The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

There have been 181 cases of acute/chronic pancreatitis and five deaths linked to Mounjaro, while Ozempic and Wegovy have one death and 113 pancreatitis reports attached to them (via Sky News).